acetylcysteine has been researched along with Drug Withdrawal Symptoms in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Cano-Cebrián, MJ; Fernández-Rodríguez, S; Granero, L; Hipólito, L; Polache, A; Zornoza, T | 1 |
| Goudriaan, AE; Kaag, AM; Kooi, DP; Schmaal, L; Schulte, M; van den Brink, W; Wiers, RW | 1 |
| Cox, S; Dawkins, L; Doig, M; Goniewicz, M; Kimber, C; Kośmider, L; McRobbie, H | 1 |
| al'Absi, M; Allen, SS; Benowitz, NL; Carmella, SG; Chen, M; Cinciripini, PM; Denlinger-Apte, R; Donny, EC; Drobes, DJ; Hatsukami, DK; Hecht, SS; Jensen, JA; Koopmeiners, JS; Lane, T; Le, CT; Leischow, S; Luo, K; Luo, X; McClernon, FJ; Murphy, SE; Paiano, V; Robinson, JD; Severson, H; Sipe, C; Strasser, AA; Strayer, LG; Tang, MK; Vandrey, R | 1 |
| Bimonte-Nelson, HA; Gipson, CD; Goenaga, J; Koebele, SV; Leyrer-Jackson, JM; McClure, EA; Namba, MD; Phan, S; Piña, J; Powell, GL; Prakapenka, AV | 1 |
| da Rosa Araujo, AS; Herrmann, AP; Marcon, M; Mocelin, R; Piato, A | 1 |
| Gipson, CD; Gray, KM; Kalivas, PW; Malcolm, RJ; McClure, EA | 1 |
| Karimian Sichani, N; Maracy, M; Mousavi, SG; Peykanpour, M; Salehi, M; Sharbafchi, MR | 1 |
| Clarimundo, V; Dalmaz, C; Elisabetsky, E; Gomez, R; Santos, CF; Schneider, R | 1 |
| Froeliger, B; Gray, KM; Kalivas, PW; McClure, EA; McConnell, PA; Stankeviciute, N | 1 |
| Bowers, MS; Damaj, MI; Jackson, A; Maldoon, PP | 1 |
| Baker, NL; Cloud, K; Gray, KM; Killeen, TK; McRae-Clark, AL; Sherman, BJ; Sonne, SC | 1 |
| Hedden, S; Kalivas, PW; Knackstedt, LA; LaRowe, S; Malcolm, R; Mardikian, P; Markou, A; Upadhyaya, H | 1 |
| Gass, JT; Kalivas, PW; Lavin, A; Moran, M; Moussawi, K; Olive, MF; Pacchioni, A | 1 |
| Do, PH; Kalivas, PW; Moussawi, K; Reichel, CM; See, RE | 1 |
| Baker, NL; Gray, KM; Roten, AT | 1 |
| Baker, DA; Kalivas, PW; Lake, RW; McFarland, K; Shen, H; Tang, XC; Toda, S | 1 |
| Downey, HF; Jung, ME; Mallet, RT; Simpkins, JW; Wilson, AM | 1 |
1 review(s) available for acetylcysteine and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Potential role of N-acetylcysteine in the management of substance use disorders.
Topics: Acetylcysteine; Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Molecular Structure; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome | 2014 |
7 trial(s) available for acetylcysteine and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
The effect of N-acetylcysteine on brain glutamate and gamma-aminobutyric acid concentrations and on smoking cessation: A randomized, double-blind, placebo-controlled trial.
Topics: Acetylcysteine; Adult; Craving; Double-Blind Method; gamma-Aminobutyric Acid; Glutamic Acid; Gyrus Cinguli; Humans; Male; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2017 |
Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial.
Topics: Acetylcysteine; Adult; Area Under Curve; Biomarkers; Breath Tests; Carbon Monoxide; Creatinine; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotiana; Nicotine; Phenanthrenes; Smoke; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder | 2018 |
The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
Topics: Acetylcysteine; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Craving; Cross-Over Studies; Double-Blind Method; Female; Free Radical Scavengers; Humans; Male; Methamphetamine; Substance Withdrawal Syndrome; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2015 |
The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study.
Topics: Acetylcysteine; Adult; Corpus Striatum; Double-Blind Method; Female; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Pilot Projects; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study.
Topics: Acetylcysteine; Adult; Cannabinoids; Comorbidity; Female; Free Radical Scavengers; Help-Seeking Behavior; Humans; Male; Marijuana Abuse; Mental Disorders; Middle Aged; Patient Acceptance of Health Care; Patient Care Management; Sex Factors; Substance Withdrawal Syndrome | 2017 |
The role of cystine-glutamate exchange in nicotine dependence in rats and humans.
Topics: Acetylcysteine; Amino Acid Transport System y+; Amygdala; Animals; Brain; Carbon Monoxide; Excitatory Amino Acid Transporter 2; Female; Humans; Male; Middle Aged; Nicotine; Nucleus Accumbens; Pilot Projects; Prefrontal Cortex; Rats; Rats, Wistar; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder; Ventral Tegmental Area | 2009 |
Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial.
Topics: Acetylcysteine; Adolescent; Combined Modality Therapy; Counseling; Drug Administration Schedule; Excitatory Amino Acid Agonists; Female; Humans; Male; Marijuana Abuse; Self Report; Substance Withdrawal Syndrome; Young Adult | 2013 |
10 other study(ies) available for acetylcysteine and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Efficacy of N-acetylcysteine in the prevention of alcohol relapse-like drinking: Study in long-term ethanol-experienced male rats.
Topics: Acetylcysteine; Alcohol Drinking; Alcoholism; Animals; Drug Evaluation, Preclinical; Ethanol; Infusions, Subcutaneous; Injections, Subcutaneous; Male; Models, Animal; Random Allocation; Rats; Rats, Wistar; Recurrence; Substance Withdrawal Syndrome | 2021 |
'Real-world' compensatory behaviour with low nicotine concentration e-liquid: subjective effects and nicotine, acrolein and formaldehyde exposure.
Topics: Acetylcysteine; Acrolein; Adult; Cotinine; Craving; England; Female; Formaldehyde; Formates; Humans; Inhalation Exposure; Male; Middle Aged; Nicotine; Nicotinic Agonists; Saliva; Substance Withdrawal Syndrome; Vaping; Young Adult | 2018 |
N-acetylcysteine yields sex-specific efficacy for cue-induced reinstatement of nicotine seeking.
Topics: Acetylcysteine; Animals; Craving; Cues; Disease Models, Animal; Drug-Seeking Behavior; Estrous Cycle; Extinction, Psychological; Female; Free Radical Scavengers; Male; Nicotine; Rats; Rats, Sprague-Dawley; Sex Factors; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2020 |
Withdrawal effects following repeated ethanol exposure are prevented by N-acetylcysteine in zebrafish.
Topics: Acetylcysteine; Animals; Anxiety; Brain; Catalase; Disease Models, Animal; Ethanol; Female; Lipid Peroxidation; Male; Oxidative Stress; Substance Withdrawal Syndrome; Superoxide Dismutase; Zebrafish | 2019 |
N-acetylcysteine prevents behavioral and biochemical changes induced by alcohol cessation in rats.
Topics: Acetylcysteine; Animals; Anxiety; Behavior, Animal; Central Nervous System Depressants; Corticosterone; Ethanol; Free Radical Scavengers; Leptin; Motor Activity; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2015 |
N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice.
Topics: Acetylcysteine; Animals; Association Learning; Dose-Response Relationship, Drug; Male; Mecamylamine; Mice; Mice, Inbred ICR; Nicotine; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2016 |
N-Acetylcysteine reverses cocaine-induced metaplasticity.
Topics: Acetylcysteine; Animals; Behavior, Animal; Cocaine-Related Disorders; Disease Models, Animal; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Free Radical Scavengers; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Neuronal Plasticity; Nucleus Accumbens; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Secondary Prevention; Self Administration; Substance Withdrawal Syndrome | 2009 |
Chronic N-acetylcysteine during abstinence or extinction after cocaine self-administration produces enduring reductions in drug seeking.
Topics: Acetylcysteine; Animals; Cocaine; Cocaine-Related Disorders; Cues; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Glutamic Acid; Homeostasis; Male; Rats; Rats, Sprague-Dawley; Recurrence; Self Administration; Substance Withdrawal Syndrome | 2011 |
Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse.
Topics: Acetylcysteine; Adaptation, Physiological; Analysis of Variance; Animals; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Corpus Striatum; Cystine; Dose-Response Relationship, Drug; Expectorants; Extinction, Psychological; Extracellular Space; Glutamic Acid; Male; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Recurrence; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome; Time Factors | 2003 |
Intermittent hypoxia conditioning prevents behavioral deficit and brain oxidative stress in ethanol-withdrawn rats.
Topics: Acetylcysteine; Animals; Antioxidants; Behavior, Animal; Brain Chemistry; Central Nervous System Depressants; Dextrins; Diet; Ethanol; Hypoxia; Ischemic Preconditioning; Male; Mitochondria; Mitochondrial Membranes; Mitochondrial Swelling; Oxidants; Oxidative Stress; Protein Carbonylation; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Superoxides | 2008 |